| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/30/2004 | US20040191867 DNA sequences coding for a mammalian glucuronyl C5-epimerase and a process for its production |
| 09/30/2004 | US20040191865 Using transgenic cells for propagation of heterologous proteins; bioreactors |
| 09/30/2004 | US20040191840 Using immunoglobulins to inactivate viricidal and antitumor activities of huma n type interferon for preventing autoimmunity and graft rejection; immunosuppressants |
| 09/30/2004 | US20040191839 Methods for sorting undifferentiated cells and uses thereof |
| 09/30/2004 | US20040191829 Comprises peptide associated with sugar transport protein for identifying modulators for treatment and prevention of cell proliferative disorder |
| 09/30/2004 | US20040191826 Dipeptidyl peptidases |
| 09/30/2004 | US20040191805 Nucleotide sequences coding g-protein coupled receptors for identifying modulators of sweet taste transduction; sweetners and flavoring; tastands and food treatment |
| 09/30/2004 | US20040191791 Comprises nucleotide sequences coding sodium voltage gated channels for identifying modulators for treatment of epilepsy; diagnosis of seizure disorders |
| 09/30/2004 | US20040191767 Comprises nucleotide sequences coding hepatitis core protein fusion for generating vaccine to prevent infcetion and treat liver dysfunction; gene therapy and cell-mediated immune response |
| 09/30/2004 | US20040191763 HBV mutations associated with reduced susceptibility to adefovir |
| 09/30/2004 | US20040191292 Having both micropores and connecting channels containing silicon, calcium and phosphorus microparticles; inducing proliferation and differentiation of human osteoblasts induction; new bone formation and calcification promotion |
| 09/30/2004 | US20040191268 Isolated, synthetic or recombinant nonapeptide of a minor Histocompatability antigen HA-1 comprising the sequence valine-leucine-X-aspartic acid-aspartic acid-leucine-leucine-glutamic acid-alanine wherein X is arginine or histidine; bone marrow transplants; graft versus host disease; leukemia |
| 09/30/2004 | US20040191235 Method for obtaining antigen-specific tr1 regulatory lymphocytes |
| 09/30/2004 | US20040191230 Pharmaceutical composition for the diagnosis, prevention or treatment of a tumoral pathology comprising an agent modulating the polymerization state of actin |
| 09/30/2004 | US20040191228 Methods of kidney transplantation utilizing developing nephric tissue |
| 09/30/2004 | US20040191227 Induction of immunological tolerance |
| 09/30/2004 | US20040191225 Injecting isolated cell through needle into organ, tissue, or tumor; drug delivery; carrier aids in retention of cells at injection site, or a tissue sealant or film to seal; tissue engineering; gene therapy |
| 09/30/2004 | US20040191173 Metastasis models using green fluorescent protein (GFP) as a marker |
| 09/30/2004 | CA2855229A1 Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure |
| 09/30/2004 | CA2523986A1 Method for forming organ |
| 09/30/2004 | CA2520629A1 Methods of promoting the differentiation of stem cells |
| 09/30/2004 | CA2519084A1 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells |
| 09/30/2004 | CA2518496A1 Accelerated culture system for intestinal epithelial cell monolayers |
| 09/29/2004 | EP1462457A1 Cytotoxic protein and utilization thereof |
| 09/29/2004 | EP1462456A1 Tumor antigens |
| 09/29/2004 | EP1461450A1 T-bet compositions and methods of use thereof |
| 09/29/2004 | EP1461446A2 Lipid-associated molecules |
| 09/29/2004 | EP1461443A2 Carbohydrate-associated proteins |
| 09/29/2004 | EP1461442A2 TRANSGENIC ANIMALS BEARING HUMAN Ig Lambda LIGHT CHAIN GENES |
| 09/29/2004 | EP1461441A1 Flavivirus vaccine delivery system |
| 09/29/2004 | EP1461440A2 Cultured cells from pancreatic islets |
| 09/29/2004 | EP1461437A2 Expression vectors and promoters for heterologous gene expression |
| 09/29/2004 | EP1461431A2 Variants of adp-glucose pyrophosphorylase affecting phosphate sensitivity and other parameters |
| 09/29/2004 | EP1461430A2 Ovomucoid promoter and methods of use |
| 09/29/2004 | EP1461427A2 Methods for targeted expression of therapeutic nucleic acid |
| 09/29/2004 | EP1461423A2 Antibody categorization based on binding characteristics |
| 09/29/2004 | EP1461422A1 Interleukin-2 gene transferred lymphokine activated killer cells |
| 09/29/2004 | EP1461421A2 A method for the establishment of a pluripotent human blastocyst-derived stem cell line |
| 09/29/2004 | EP1461420A2 Cell culture media |
| 09/29/2004 | EP1461359A2 Novel anti-igf-ir antibodies and uses thereof |
| 09/29/2004 | EP1461358A1 Ifnar2 muteins, their production and use |
| 09/29/2004 | EP1461357A2 Novel hev antigenic peptide and methods |
| 09/29/2004 | EP1461351A2 Methods and reagents for diagnosis and treatment of diabetes |
| 09/29/2004 | EP1461349A2 Antisense modulation of mhc class ii transactivator expression |
| 09/29/2004 | EP1461093A1 Milk protein biofilm and uses thereof |
| 09/29/2004 | EP1461087A1 Use of cd34+ hematopoietic progenitor cells for the treatment of cns disorders |
| 09/29/2004 | EP1461079A2 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof |
| 09/29/2004 | EP1461073A2 Peptide agonists of prostate-specific antigen, and uses therefor |
| 09/29/2004 | EP1461072A1 Proteases producing an altered immunological response and methods of making and using the same |
| 09/29/2004 | EP1460930A2 Eb matrix production from animal tissue and its use for tissue repair |
| 09/29/2004 | EP1307247B1 Collagen membrane arranged at macromolecular level |
| 09/29/2004 | EP1196540B1 Tissue maintaining system |
| 09/29/2004 | EP1137808B1 Methods for making recombinant cells |
| 09/29/2004 | EP1112347A4 Methods for generating doubled haploid plants |
| 09/29/2004 | EP1060185A4 Isolated nucleic acid molecules which encode tage molecules, and uses thereof |
| 09/29/2004 | EP1005486A4 Inducible regulatory system and use thereof |
| 09/29/2004 | EP0983095B1 Peptide-coated implants and methods for producing them |
| 09/29/2004 | EP0980426B1 TYROSINE PHOSPHORYLATED CLEAVAGE FURROW-ASSOCIATED PROTEINS (PSTPIPs) |
| 09/29/2004 | EP0970119A4 Synaptic activation protein compositions and method |
| 09/29/2004 | EP0956045B1 Assembly-deficient herpesvirus vaccine |
| 09/29/2004 | EP0938572B1 Promoter from tobacco |
| 09/29/2004 | EP0914417B1 Human dnase ii |
| 09/29/2004 | EP0900279B1 Improved transformation method for plants |
| 09/29/2004 | EP0699079B1 Bioactive and/or targeted dendrimer conjugates comprising genetic materials |
| 09/29/2004 | CN1533437A DNA sequences for regulating transcription |
| 09/29/2004 | CN1533436A Rapid method of selecting cells for gene disruption by homologous recombination |
| 09/29/2004 | CN1533435A Methods and reagents for diagnosis and treatment of insulin resistance and related conditions |
| 09/29/2004 | CN1533432A COmpositions and methods for high-level, large-scale production of recombinant proteins |
| 09/29/2004 | CN1533431A Methods and reagents for cell transplantation |
| 09/29/2004 | CN1532280A Method for producing nerve cell from stem cell and medium for culturing stem cell |
| 09/29/2004 | CN1168824C Nucleic acid sequence encoding beta-C-4-oxygenase from haematococcus pulvialis for biosynthesis of astaxanthin |
| 09/29/2004 | CN1168823C Sweet potato embryonal suspension cell genetic transformation method |
| 09/29/2004 | CN1168741C Monoclonal antibody anti alpha; V-integrin and it use to inhibit alpha; beta; 6-integrain attachment to fibronectine |
| 09/29/2004 | CN1168740C Cell factor gene modified antigen presentation cel/tumor cell conjugate, its preparation and use |
| 09/29/2004 | CN1168736C Composition and method for delivery of nucleic acids |
| 09/29/2004 | CN1168500C Method for generating bi-RNA-virus from synthetic RNA transcripts |
| 09/28/2004 | USRE38604 And d-betahydroxybutyrate, or acetoacetate anions; electrolyte solutions for electrolyte and fluid therapy, parenteral nutrition and dialysis |
| 09/28/2004 | US6797861 Seed shattering |
| 09/28/2004 | US6797860 Promoter derived from phytosulfokine precursor gene |
| 09/28/2004 | US6797859 Vascular tissue preferred promoters |
| 09/28/2004 | US6797816 Used to modify growth and differentiation of cells, as well as viral infection and inflammation; for cancer therapy |
| 09/28/2004 | US6797812 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of ischemic injury, nervous system and inflammatory disorders |
| 09/28/2004 | US6797811 Antibodies to chemokine receptor 88C |
| 09/28/2004 | US6797809 Multiple fusion antigens for use in immunoassays for anti-HCV antibodies |
| 09/28/2004 | US6797806 Multimeric proteins;for diagnosis and therapy of disorders involving complement activity (globulins) and various inflammatory and immune disorders |
| 09/28/2004 | US6797690 Anti-freeze polypeptides for improving the freezing tolerance of foodstuffs |
| 09/28/2004 | US6797515 Regulated autocrine growth of mammalian cells |
| 09/28/2004 | US6797514 Simultaneous stimulation and concentration of cells |
| 09/28/2004 | US6797511 Basis of its ability to bind to presenilin 1; for treatment of alzheimer's disease |
| 09/28/2004 | US6797499 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 09/28/2004 | US6797498 B, B-carotene 15, 15′-dioxygenases, nucleic acid sequences coding therefor and their use |
| 09/28/2004 | US6797487 Polynucleotides encoding alzheimer's disease secretase |
| 09/28/2004 | US6797486 Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
| 09/28/2004 | US6797480 Purification of heat shock/stress protein cell surface receptors and their use as immunotherapeutic agents |
| 09/28/2004 | US6797479 Reagents and methods for the detection and quantification of vancomycin in biological fluids |
| 09/28/2004 | US6797475 Detection of polymorphisms in the human 5-lipoxygenase gene |
| 09/28/2004 | US6797467 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
| 09/28/2004 | US6797462 For determining host hiv titer, drug sensitivity, hiv amplification, gene sequencing and co-receptor utilization |
| 09/28/2004 | US6797274 Compounds |
| 09/28/2004 | US6797269 Mesenchymal stem cells as immunosuppressants |